Polymeric Prodrug Microspheres with Tumor Intracellular Microenvironment Bioreducible Degradation, Ph-Triggered “Off-On” Fluorescence and Drug Release for Precise Imaging-Guided Diagnosis and Chemotherapy

Mingliang Pei,Guoping Li,Kangwei Ma,Jianan Li,Yuanfan Wang,Peng Liu
DOI: https://doi.org/10.1016/j.colsurfb.2019.02.002
IF: 5.999
2019-01-01
Colloids and Surfaces B Biointerfaces
Abstract:Theranostic nanoplatforms have been recognized for imaging-guided diagnosis and chemotherapy of cancer by integrating imaging function into the drug delivery systems (DDSs). Here, a facile approach was developed for the fabrication of polymeric prodrug microspheres by introducing pH sensitive "off-on" fluorochrome Rhodamine 6G into bioreducible cleavable bisulfide crosslinked PEGylated poly(glycidyl methacrylate) (PEG-PGMA) microspheres, followed with chemical conjugation of doxorubicin (DOX) via an acid-labile hydrazone linkage. High drug content of 25.4% was achieved for the final PEG-PGMA-Hy-DOX prodrug microspheres with average hydrodynamic diameter of 332 nm. The in vitro controlled release showed leakage-free in physiological medium but a sustained drug release up to 58% within 56 h in tumor intracellular microenvironment. The cellular experiments showed that the PEG-PGMA-Hy-DOX prodrug microspheres could be effectively internalized into HepG2 cells with enhanced anti-tumor efficacy than the free DOX. Furthermore, they showed fluorescence only in tumor intracellular microenvironment, indicating their promising potential for precise imaging-guided diagnosis and chemotherapy.
What problem does this paper attempt to address?